These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31502661)

  • 1. Metabolic engineering of a robust Escherichia coli strain with a dual protection system.
    Ou XY; Wu XL; Peng F; Zeng YJ; Li HX; Xu P; Chen G; Guo ZW; Yang JG; Zong MH; Lou WY
    Biotechnol Bioeng; 2019 Dec; 116(12):3333-3348. PubMed ID: 31502661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A programmable CRISPR/Cas9-based phage defense system for Escherichia coli BL21(DE3).
    Liu L; Zhao D; Ye L; Zhan T; Xiong B; Hu M; Bi C; Zhang X
    Microb Cell Fact; 2020 Jul; 19(1):136. PubMed ID: 32620105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward industrial production of isoprenoids in Escherichia coli: Lessons learned from CRISPR-Cas9 based optimization of a chromosomally integrated mevalonate pathway.
    Alonso-Gutierrez J; Koma D; Hu Q; Yang Y; Chan LJG; Petzold CJ; Adams PD; Vickers CE; Nielsen LK; Keasling JD; Lee TS
    Biotechnol Bioeng; 2018 Apr; 115(4):1000-1013. PubMed ID: 29278415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid and marker-free refactoring of xylose-fermenting yeast strains with Cas9/CRISPR.
    Tsai CS; Kong II; Lesmana A; Million G; Zhang GC; Kim SR; Jin YS
    Biotechnol Bioeng; 2015 Nov; 112(11):2406-11. PubMed ID: 25943337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Based Construction of a BL21 (DE3)-Derived Variant Strain Library to Rapidly Improve Recombinant Protein Production.
    Li ZJ; Zhang ZX; Xu Y; Shi TQ; Ye C; Sun XM; Huang H
    ACS Synth Biol; 2022 Jan; 11(1):343-352. PubMed ID: 34919397
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic engineering of Escherichia coli for producing adipic acid through the reverse adipate-degradation pathway.
    Zhao M; Huang D; Zhang X; Koffas MAG; Zhou J; Deng Y
    Metab Eng; 2018 May; 47():254-262. PubMed ID: 29625225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced integration of large DNA into E. coli chromosome by CRISPR/Cas9.
    Chung ME; Yeh IH; Sung LY; Wu MY; Chao YP; Ng IS; Hu YC
    Biotechnol Bioeng; 2017 Jan; 114(1):172-183. PubMed ID: 27454445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic engineering of Escherichia coli for high-yield uridine production.
    Wu H; Li Y; Ma Q; Li Q; Jia Z; Yang B; Xu Q; Fan X; Zhang C; Chen N; Xie X
    Metab Eng; 2018 Sep; 49():248-256. PubMed ID: 30189293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9-mediated engineering of Escherichia coli for n-butanol production from xylose in defined medium.
    Abdelaal AS; Jawed K; Yazdani SS
    J Ind Microbiol Biotechnol; 2019 Jul; 46(7):965-975. PubMed ID: 30982114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tunable expression rate control of a growth-decoupled T7 expression system by L-arabinose only.
    Stargardt P; Striedner G; Mairhofer J
    Microb Cell Fact; 2021 Feb; 20(1):27. PubMed ID: 33522916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fermentation of dihydroxyacetone by engineered
    Wang L; Chauliac D; Rhee MS; Panneerselvam A; Ingram LO; Shanmugam KT
    Proc Natl Acad Sci U S A; 2018 Apr; 115(17):4381-4386. PubMed ID: 29632200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthesis of D-glucaric acid from sucrose with routed carbon distribution in metabolically engineered Escherichia coli.
    Qu YN; Yan HJ; Guo Q; Li JL; Ruan YC; Yue XZ; Zheng WX; Tan TW; Fan LH
    Metab Eng; 2018 May; 47():393-400. PubMed ID: 29715517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematically chromosomally engineered Escherichia coli efficiently produces butanol.
    Dong H; Zhao C; Zhang T; Zhu H; Lin Z; Tao W; Zhang Y; Li Y
    Metab Eng; 2017 Nov; 44():284-292. PubMed ID: 29102594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stringent regulation and high-level expression of heterologous genes in Escherichia coli using T7 system controllable by the araBAD promoter.
    Chao YP; Chiang CJ; Hung WB
    Biotechnol Prog; 2002; 18(2):394-400. PubMed ID: 11934312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a novel lytic bacteriophage from an industrial Escherichia coli fermentation process and elimination of virulence using a heterologous CRISPR-Cas9 system.
    Halter MC; Zahn JA
    J Ind Microbiol Biotechnol; 2018 Mar; 45(3):153-163. PubMed ID: 29411201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic engineering of microbial competitive advantage for industrial fermentation processes.
    Shaw AJ; Lam FH; Hamilton M; Consiglio A; MacEwen K; Brevnova EE; Greenhagen E; LaTouf WG; South CR; van Dijken H; Stephanopoulos G
    Science; 2016 Aug; 353(6299):583-6. PubMed ID: 27493184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covalent Modification of Bacteriophage T4 DNA Inhibits CRISPR-Cas9.
    Bryson AL; Hwang Y; Sherrill-Mix S; Wu GD; Lewis JD; Black L; Clark TA; Bushman FD
    mBio; 2015 Jun; 6(3):e00648. PubMed ID: 26081634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization, complete genome sequencing, and CRISPR/Cas9 system-based decontamination of a novel
    Dong Y; Huang Y; Fan H; Song L; An X; Xu S; Li M; Tong Y
    Front Microbiol; 2023; 14():1230775. PubMed ID: 37637117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the expression of recombinant Cas9 protein in E. coli BL21(DE3) and BL21(DE3) Rosetta strains.
    Carmignotto GP; Azzoni AR
    J Biotechnol; 2019 Dec; 306():62-70. PubMed ID: 31545973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved bioethanol production using CRISPR/Cas9 to disrupt the ADH2 gene in Saccharomyces cerevisiae.
    Xue T; Liu K; Chen D; Yuan X; Fang J; Yan H; Huang L; Chen Y; He W
    World J Microbiol Biotechnol; 2018 Oct; 34(10):154. PubMed ID: 30276556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.